UnitedHealth Group Incorporated

UNH · Healthcare

$379.66
+2.25% today

What a holder would want to know before buying UNH: where the price sits in its own history, how far it has fallen before and whether it recovered, and what the business behind it earns. All of it is arithmetic over free market data — no opinions, no recommendations.

Where the price sits
Low $259.02 · Mar 2026High $436.35 · Jul 2026

Today’s price is 46% above the lowest point of the past year and 13% below the highest.

Over the past year it was cheaper than today on 66% of days and more expensive on 34%. Over the last 10 years: cheaper on 57% of days.

6% above its average price of the last 200 trading days.

How bad does it get

Fell 20% or more 4 times in 10 years. The deepest fall was 62%; the longest took 21 months to get back to its peak. 3 of 4 have recovered so far.

It is in one now: 39% below the Nov 2024 peak.

Nov 2024
−62%not back yet
Oct 2022
−21%back in 21 months
Feb 2020
−36%back in 3 months
Dec 2018
−25%back in 12 months
What you own

UnitedHealth Group Incorporated · Healthcare · Healthcare Plans · a mega-cap worth $340.46B

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum…

Is it making money?
2022
2023
2024
2025

revenue profit

Sales of $447.57B in 2025, with $12.06B of profit. Sales grew in 3 of the last 3 years.

Keeps about 3 cents of every dollar of sales as profit.

Is it healthy?
Cash
$31.47B
Debt
$73.33B
Free cash flow / yr
$24.27B

Would need about 3 years of free cash flow to repay all its debt.

Is it expensive?

You pay $24 for every $1 of last year’s profit, and $17 for every $1 of profit expected next year.

A high number means buyers expect growth; a low one means they expect little, or fear trouble. Large US companies have averaged roughly 15–20 over the decades.

Pays 2.50% a year in dividends at today’s price · next ex-dividend Sep 14.

What others are doing

26 analysts: 22 say buy, 4 hold, 0 sell. Their average 12-month target is $481.72 (range $380.00–$529.00).

Insiders made 0 purchases and 3 sales in the last 6 months. Executives routinely sell shares they were paid in; buying with their own money is the rarer signal.

Free data from Yahoo Finance, refreshed daily. This is evidence about the business and its price history, not a recommendation.

Now try it without risking anything

Poshkan is paper trading: real prices, virtual money. Buy UNH with $10,000 that isn’t real, set a stop before you enter, and find out what your idea would actually have done.

Data from Yahoo Finance, refreshed hourly. Nothing here is financial advice. Poshkan is a paper-trading simulator — all money, trades and returns are virtual.